1. Home
  2. JELD vs VIR Comparison

JELD vs VIR Comparison

Compare JELD & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JELD
  • VIR
  • Stock Information
  • Founded
  • JELD 1960
  • VIR 2016
  • Country
  • JELD United States
  • VIR United States
  • Employees
  • JELD N/A
  • VIR N/A
  • Industry
  • JELD Forest Products
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • JELD Basic Materials
  • VIR Health Care
  • Exchange
  • JELD Nasdaq
  • VIR Nasdaq
  • Market Cap
  • JELD 868.7M
  • VIR 1.0B
  • IPO Year
  • JELD 2017
  • VIR 2019
  • Fundamental
  • Price
  • JELD $10.48
  • VIR $6.95
  • Analyst Decision
  • JELD Hold
  • VIR Buy
  • Analyst Count
  • JELD 11
  • VIR 5
  • Target Price
  • JELD $14.90
  • VIR $36.40
  • AVG Volume (30 Days)
  • JELD 1.2M
  • VIR 1.6M
  • Earning Date
  • JELD 11-04-2024
  • VIR 10-31-2024
  • Dividend Yield
  • JELD N/A
  • VIR N/A
  • EPS Growth
  • JELD N/A
  • VIR N/A
  • EPS
  • JELD N/A
  • VIR N/A
  • Revenue
  • JELD $3,900,923,000.00
  • VIR $78,618,000.00
  • Revenue This Year
  • JELD N/A
  • VIR N/A
  • Revenue Next Year
  • JELD N/A
  • VIR N/A
  • P/E Ratio
  • JELD N/A
  • VIR N/A
  • Revenue Growth
  • JELD N/A
  • VIR N/A
  • 52 Week Low
  • JELD $8.90
  • VIR $6.56
  • 52 Week High
  • JELD $21.75
  • VIR $13.09
  • Technical
  • Relative Strength Index (RSI)
  • JELD 34.52
  • VIR 36.25
  • Support Level
  • JELD $9.84
  • VIR $9.48
  • Resistance Level
  • JELD $10.34
  • VIR $10.13
  • Average True Range (ATR)
  • JELD 0.63
  • VIR 0.57
  • MACD
  • JELD -0.03
  • VIR -0.32
  • Stochastic Oscillator
  • JELD 27.48
  • VIR 10.05

About JELD JELD-WEN Holding Inc.

JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: